Johnson & Johnson seeks EMA approval for Ebola vaccine regimen

This article was originally published here

The company has submitted marketing authorisation applications (MAAs) to the EMA to prevent Ebola Virus Disease (EVD) caused by Zaire ebolavirus species. Janssen has submitted two MAAs in

The post Johnson & Johnson seeks EMA approval for Ebola vaccine regimen appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply